2023 Q3 Form 10-Q Financial Statement

#000160402823000038 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $780.2M $778.0M $914.2M
YoY Change -11.76% -14.89% 36.59%
Cost Of Revenue $477.5M $446.6M $562.1M
YoY Change -15.37% -20.55% 20.06%
Gross Profit $302.7M $331.5M $352.1M
YoY Change -5.4% -5.86% 75.07%
Gross Profit Margin 38.79% 42.6% 38.52%
Selling, General & Admin $91.70M $86.51M $86.52M
YoY Change 3.45% -0.01% 13.51%
% of Gross Profit 30.3% 26.1% 24.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $36.80M $37.24M $35.58M
YoY Change 2.44% 4.67% 102.93%
% of Gross Profit 12.16% 11.24% 10.1%
Operating Expenses $104.6M $99.31M $100.2M
YoY Change 2.07% -0.88% 31.46%
Operating Profit $198.0M $232.1M $251.6M
YoY Change -8.98% -7.73% 130.27%
Interest Expense -$21.94M -$18.16M -$11.07M
YoY Change 20.15% 64.04% 40.03%
% of Operating Profit -11.08% -7.82% -4.4%
Other Income/Expense, Net $7.506M $3.549M $1.902M
YoY Change -2000.25% 86.59% -5.56%
Pretax Income $183.6M $227.3M $242.4M
YoY Change -7.7% -6.25% 134.53%
Income Tax $47.48M $55.06M $55.07M
% Of Pretax Income 25.86% 24.22% 22.71%
Net Earnings $135.8M $173.7M $187.1M
YoY Change -10.66% -7.21% 146.29%
Net Earnings / Revenue 17.41% 22.32% 20.47%
Basic Earnings Per Share $1.73 $2.20 $2.25
Diluted Earnings Per Share $1.71 $2.18 $2.22
COMMON SHARES
Basic Shares Outstanding 78.69M shares 78.97M shares 83.14M shares
Diluted Shares Outstanding 79.31M shares 79.63M shares 84.39M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $470.4M $366.1M $463.7M
YoY Change 2.85% -21.05% 224.64%
Cash & Equivalents $470.4M $366.1M $463.7M
Short-Term Investments
Other Short-Term Assets $23.86M $25.45M $20.53M
YoY Change 1.94% 23.95% 12.11%
Inventory $385.1M $434.6M $489.5M
Prepaid Expenses
Receivables $352.6M $342.3M $427.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.232B $1.169B $1.401B
YoY Change -8.6% -16.61% 76.14%
LONG-TERM ASSETS
Property, Plant & Equipment $774.0M $747.3M $636.0M
YoY Change 18.45% 17.49% 22.73%
Goodwill $620.2M $620.4M $619.6M
YoY Change 0.11% 0.13%
Intangibles $382.1M $394.8M $449.1M
YoY Change -12.23% -12.09%
Long-Term Investments
YoY Change
Other Assets $129.9M $117.6M $119.2M
YoY Change 6.86% -1.4% 25.31%
Total Long-Term Assets $1.906B $1.880B $1.824B
YoY Change 4.17% 3.08% 8.64%
TOTAL ASSETS
Total Short-Term Assets $1.232B $1.169B $1.401B
Total Long-Term Assets $1.906B $1.880B $1.824B
Total Assets $3.138B $3.049B $3.225B
YoY Change -1.25% -5.48% 30.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $223.5M $205.6M $274.6M
YoY Change -5.52% -25.13% 19.76%
Accrued Expenses $158.8M $137.5M $148.6M
YoY Change -6.46% -7.47% 19.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.95M $24.25M $18.11M
YoY Change -22.76% 33.9% 158.76%
Total Short-Term Liabilities $427.9M $419.6M $504.8M
YoY Change -2.6% -16.87% 23.88%
LONG-TERM LIABILITIES
Long-Term Debt $1.264B $1.296B $1.279B
YoY Change -0.86% 1.28% 63.88%
Other Long-Term Liabilities $72.94M $62.68M $66.47M
YoY Change 6.36% -5.7% 6.39%
Total Long-Term Liabilities $1.337B $1.358B $1.346B
YoY Change -0.5% 0.94% 72.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $427.9M $419.6M $504.8M
Total Long-Term Liabilities $1.337B $1.358B $1.346B
Total Liabilities $1.956B $1.956B $2.029B
YoY Change -0.31% -3.6% 38.64%
SHAREHOLDERS EQUITY
Retained Earnings $913.6M $788.8M $335.8M
YoY Change 91.2% 134.88%
Common Stock $1.185B $1.159B $1.091B
YoY Change 4.79% 6.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.029B $1.093B $990.0M
YoY Change
Total Liabilities & Shareholders Equity $3.138B $3.049B $3.225B
YoY Change -1.25% -5.48% 30.34%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $135.8M $173.7M $187.1M
YoY Change -10.66% -7.21% 146.29%
Depreciation, Depletion And Amortization $36.80M $37.24M $35.58M
YoY Change 2.44% 4.67% 102.93%
Cash From Operating Activities $214.9M $244.0M $249.8M
YoY Change 14.76% -2.32% 139.36%
INVESTING ACTIVITIES
Capital Expenditures $40.55M $42.08M $36.19M
YoY Change 3.03% 16.27% 41.66%
Acquisitions $0.00 $47.49M
YoY Change -100.0%
Other Investing Activities $300.0K $20.13M -$13.00K
YoY Change -161.86% -154976.92% -75.47%
Cash From Investing Activities -$40.30M -$21.94M -$83.67M
YoY Change 1.15% -73.77% 228.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$57.70M
YoY Change -128.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -69.90M -73.51M $277.7M
YoY Change -54.27% -126.47% -311.45%
NET CHANGE
Cash From Operating Activities 214.9M 244.0M $249.8M
Cash From Investing Activities -40.30M -21.94M -$83.67M
Cash From Financing Activities -69.90M -73.51M $277.7M
Net Change In Cash 104.7M 148.5M $443.6M
YoY Change -2024.99% -66.52% -950.14%
FREE CASH FLOW
Cash From Operating Activities $214.9M $244.0M $249.8M
Capital Expenditures $40.55M $42.08M $36.19M
Free Cash Flow $174.4M $201.9M $213.6M
YoY Change 17.88% -5.47% 171.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
47492000 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-155000 usd
CY2022Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-13000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21944000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83668000 usd
CY2023Q2 wms Repayments Of Syndicated Term Loan Facility
RepaymentsOfSyndicatedTermLoanFacility
1750000 usd
CY2022Q2 wms Repayments Of Syndicated Term Loan Facility
RepaymentsOfSyndicatedTermLoanFacility
1750000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
500000000 usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
11575000 usd
CY2023Q2 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
2256000 usd
CY2022Q2 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3548000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2769000 usd
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1721000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
47778000 usd
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
57699000 usd
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11084000 usd
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10170000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
867000 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1249000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8742000 usd
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
22809000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73512000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
277677000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
465000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-203000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
148976000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
443571000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217128000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20125000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366104000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
463696000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1553000 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5055000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
8499000 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
4714000 usd
CY2023Q2 wms Stock Repurchase Costs Incurred But Not Yet Paid
StockRepurchaseCostsIncurredButNotYetPaid
0 usd
CY2022Q2 wms Stock Repurchase Costs Incurred But Not Yet Paid
StockRepurchaseCostsIncurredButNotYetPaid
9662000 usd
CY2023Q2 wms Excise Tax Accrual Share Repurchase
ExciseTaxAccrualShareRepurchase
293000 usd
CY2022Q2 wms Excise Tax Accrual Share Repurchase
ExciseTaxAccrualShareRepurchase
0 usd
CY2023Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
944000 usd
CY2022Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1754000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19781000 usd
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
16881000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
909661000 usd
CY2022Q2 wms Profit Loss Excluding Portion Attributable To Redeemable Noncontrolling Interest
ProfitLossExcludingPortionAttributableToRedeemableNoncontrollingInterest
188482000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3898000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
10200000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
67361000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6556000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1249000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2457000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-20346000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6273000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1007959000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
841640000 usd
CY2023Q2 wms Profit Loss Excluding Portion Attributable To Redeemable Noncontrolling Interest
ProfitLossExcludingPortionAttributableToRedeemableNoncontrollingInterest
173905000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3232000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
11087000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
48071000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4823000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
867000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2345000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-6394000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6903000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-4000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
963469000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1167000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
933000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3857000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2664000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6903000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6273000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6903000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
98665000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
108206000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
335966000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
355788000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
434631000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
463994000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
173652000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
187146000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78908000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83144000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.25
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
173652000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
187146000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78908000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83144000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79634000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84389000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.22
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24000 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6273000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1291896000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1295888000 usd
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
11293000 usd
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
11804000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
13806000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
14693000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1266797000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1269391000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.227
CY2023Q2 us-gaap Share Price
SharePrice
96.51
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.456
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0058
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
778046000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
778046000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
914186000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
914186000 usd
CY2023Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
355072000 usd
CY2022Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
373083000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37240000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35578000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42078000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36189000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
331460000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
352107000 usd
CY2023Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
355072000 usd
CY2022Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
373083000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
173905000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
188482000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-21712000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11072000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55058000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55065000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
13304000 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-303000 usd

Files In Submission

Name View Source Status
0001604028-23-000038-index-headers.html Edgar Link pending
0001604028-23-000038-index.html Edgar Link pending
0001604028-23-000038.txt Edgar Link pending
0001604028-23-000038-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wms-06302023xexhibit311.htm Edgar Link pending
wms-06302023xexhibit312.htm Edgar Link pending
wms-06302023xexhibit321.htm Edgar Link pending
wms-06302023xexhibit322.htm Edgar Link pending
wms-20230630.htm Edgar Link pending
wms-20230630.xsd Edgar Link pending
wms-20230630_def.xml Edgar Link unprocessable
wms-20230630_lab.xml Edgar Link unprocessable
wms-20230630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
wms-20230630_cal.xml Edgar Link unprocessable
wms-20230630_pre.xml Edgar Link unprocessable